FDA was Busy in 2013 and its Sleigh is Packed Heading into the New Year
By Richard L. Frank and Michael J. O’Flaherty While often rightly the subject of criticism for delay or inaction on important regulatory matters, FDA in late 2013 has been bustling. The FDA, during...
View ArticleGood Reprint Practices Revamped
By Casper E. Uldriks The Food and Drug Administration (FDA) issued a revised draft guidance document in February 2014 entitled, “Guidance for Industry: Distributing Scientific and Medical Publications...
View Article
More Pages to Explore .....